The looming highway trust fund crisis: what will Congress do? Finding a path forward
By Evan M Migdail
Congress left for its one-week adjournment for the Independence Day holiday in the midst of intensive negotiations in both chambers to address an impending crisis in the nation’s transportation system. Absent a deal by August, the federal highway trust fund (HTF) will lack sufficient funding to support thousands of road, highway, bridge and other vital transportation maintenance and repair projects.
The HTF traditionally has been supported by federal fuel excise taxes, but these have fallen short in recent years. The current fiscal year shortfall is estimated at around $10bn (£6bn); it is estimated that over the next six years the shortfall will approach $160bn.
Because the insolvency of the HTF could adversely affect countless millions of Americans in every state, finding a solution to the crisis is both a high economic and political priority, especially with congressional elections just four-and-a-half months away…
Click on the link below to read the rest of the DLA Piper briefing.
Sign in or Register to continue reading this article
It's quick, easy and free!
It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.Register now
Why register to The Lawyer
In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.
Identify the major players and business opportunities within a particular region through our series of free, special reports.
Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.
More relevant to you
To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.
News from DLA Piper
News from The Lawyer
Briefings from DLA Piper
The Supreme Court ruled in FTC v Actavis that settlement agreements for patent infringement suits between branded and generic drug companies are not immune from antitrust scrutiny.
Arguably, Germany is the jurisdiction that has the most to lose with the introduction of the UPC.
Analysis from The Lawyer
Regulators are ramping up the pressure in the aftermath of recession, leaving firms to compete for compliance and restructuring work
Shearman & Sterling is making its presence felt in the City, squaring up to magic circle firms and looking to muscle in on key relationships. Private equity house Bridgepoint is one outfit that has had its head turned by the US firm.